Financhill
Back

Veracyte Stock Predictions

Veracyte Stock Forecast

  • Over the next 52 weeks, Veracyte has on average historically risen by 28.4% based on the past 11 years of stock performance.
  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is Veracyte Stock Undervalued?
    The current Veracyte [VCYT] share price is $39.20. The Score for VCYT is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Veracyte Stock Go Up Next Year?

  • Over the next 52 weeks, Veracyte has on average historically risen by 28.4% based on the past 11 years of stock performance.

Veracyte Stock Rating

Buy
83
Veracyte (VCYT) is a Buy

Is Veracyte overpriced?

  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Veracyte Stock Price History

Is VCYT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCYT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com

52-Week Data

52-Week High:
41.43
52-Week Low:
18.61

Prediction Charts

Market Cap:
3.04B
Price in USD:
39.20
Volume:
631.38K
Beta:
1.47

Technical Analysis

SMA50:
34.50
SMA100:
30.58
SMA200:
26.20
52-Wk Change:
50.54%

Stock Predictions

  • Is Veracyte stock public?
    Yes, Veracyte is a publicly traded company.
  • What is the Veracyte stock quote today?
    The Veracyte stock price is 39.20 USD today.
  • How to buy Veracyte stock online?
    You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 33.96 34.31 34.36 33.61
Nov-4 34.22 35.02 35.03 33.56
Nov-5 34.77 35.93 36.26 34.41
Nov-6 36.77 36.59 37.40 35.89
Nov-7 39.70 37.34 41.43 37.28
Nov-8 37.15 36.48 37.84 36.35
Nov-11 36.94 38.88 38.93 36.94
Nov-12 38.52 38.25 38.78 37.92
Nov-13 38.69 39.53 39.71 38.40
Nov-14 39.53 37.04 39.98 36.80
Nov-15 37.76 35.94 37.76 35.37
Nov-18 36.05 36.71 37.30 35.73
Nov-19 36.40 39.15 39.19 36.38
Nov-20 39.16 39.20 39.80 38.61

Veracyte Earnings

Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Veracyte Forecast Revenue Growth

Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and a decrease next year of $0.12 per share.

* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.